189 related articles for article (PubMed ID: 31457731)
1. A Small Molecule Inhibitor of Bruton's Tyrosine Kinase Involved in B-Cell Signaling.
Ratzon E; Bloch I; Nicola M; Cohen E; Ruimi N; Dotan N; Landau M; Gal M
ACS Omega; 2017 Aug; 2(8):4398-4410. PubMed ID: 31457731
[TBL] [Abstract][Full Text] [Related]
2. Role of Bruton's tyrosine kinase in B cells and malignancies.
Pal Singh S; Dammeijer F; Hendriks RW
Mol Cancer; 2018 Feb; 17(1):57. PubMed ID: 29455639
[TBL] [Abstract][Full Text] [Related]
3. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).
Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD
J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238
[TBL] [Abstract][Full Text] [Related]
4. Screening and Characterization of Allosteric Small Molecules Targeting Bruton's Tyrosine Kinase.
Kueffer LE; Lin DY; Amatya N; Serrenho J; Joseph RE; Courtney AH; Andreotti AH
Biochemistry; 2024 Jan; 63(1):94-106. PubMed ID: 38091504
[TBL] [Abstract][Full Text] [Related]
5. Pharmacophore modeling and virtual screening in search of novel Bruton's tyrosine kinase inhibitors.
Sharma A; Thelma BK
J Mol Model; 2019 Jun; 25(7):179. PubMed ID: 31172362
[TBL] [Abstract][Full Text] [Related]
6. SH3 domain of Bruton's tyrosine kinase can bind to proline-rich peptides of TH domain of the kinase and p120cbl.
Patel HV; Tzeng SR; Liao CY; Chen SH; Cheng JW
Proteins; 1997 Dec; 29(4):545-52. PubMed ID: 9408950
[TBL] [Abstract][Full Text] [Related]
7. Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X-linked agammaglobulinaemia.
Hyvönen M; Saraste M
EMBO J; 1997 Jun; 16(12):3396-404. PubMed ID: 9218782
[TBL] [Abstract][Full Text] [Related]
8. The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review.
Liang C; Tian D; Ren X; Ding S; Jia M; Xin M; Thareja S
Eur J Med Chem; 2018 May; 151():315-326. PubMed ID: 29631132
[TBL] [Abstract][Full Text] [Related]
9. The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase.
Cory GO; Lovering RC; Hinshelwood S; MacCarthy-Morrogh L; Levinsky RJ; Kinnon C
J Exp Med; 1995 Aug; 182(2):611-5. PubMed ID: 7629518
[TBL] [Abstract][Full Text] [Related]
10. Biochemical characterization of tirabrutinib and other irreversible inhibitors of Bruton's tyrosine kinase reveals differences in on - and off - target inhibition.
Liclican A; Serafini L; Xing W; Czerwieniec G; Steiner B; Wang T; Brendza KM; Lutz JD; Keegan KS; Ray AS; Schultz BE; Sakowicz R; Feng JY
Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129531. PubMed ID: 31953125
[TBL] [Abstract][Full Text] [Related]
11. Bruton's tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain.
Mohamed AJ; Yu L; Bäckesjö CM; Vargas L; Faryal R; Aints A; Christensson B; Berglöf A; Vihinen M; Nore BF; Smith CI
Immunol Rev; 2009 Mar; 228(1):58-73. PubMed ID: 19290921
[TBL] [Abstract][Full Text] [Related]
12. Targeting Bruton's Tyrosine Kinase in Inflammatory and Autoimmune Pathologies.
Neys SFH; Hendriks RW; Corneth OBJ
Front Cell Dev Biol; 2021; 9():668131. PubMed ID: 34150760
[TBL] [Abstract][Full Text] [Related]
13. Molecular and structural characterization of five novel mutations in the Bruton's tyrosine kinase gene from patients with X-linked agammaglobulinemia.
Saha BK; Curtis SK; Vogler LB; Vihinen M
Mol Med; 1997 Jul; 3(7):477-85. PubMed ID: 9260159
[TBL] [Abstract][Full Text] [Related]
14. Bruton's tyrosine kinase (Btk) associates with protein kinase C mu.
Johannes FJ; Hausser A; Storz P; Truckenmüller L; Link G; Kawakami T; Pfizenmaier K
FEBS Lett; 1999 Nov; 461(1-2):68-72. PubMed ID: 10561498
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization and function analysis of grouper (Epinephelus coioides) Bruton's tyrosine kinase BTK.
Mo ZQ; Han Q; Zeng YL; Wang JL; Li XZ; Li YW; Sun HY; Li AX; Luo XC; Dan XM
Fish Shellfish Immunol; 2018 Jun; 77():91-99. PubMed ID: 29567142
[TBL] [Abstract][Full Text] [Related]
16. Role of Bruton's tyrosine kinase in B cell development.
Maas A; Hendriks RW
Dev Immunol; 2001; 8(3-4):171-81. PubMed ID: 11785667
[TBL] [Abstract][Full Text] [Related]
17. Reining in BTK: Interdomain Interactions and Their Importance in the Regulatory Control of BTK.
Kueffer LE; Joseph RE; Andreotti AH
Front Cell Dev Biol; 2021; 9():655489. PubMed ID: 34249912
[TBL] [Abstract][Full Text] [Related]
18. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling.
Lindvall JM; Blomberg KE; Väliaho J; Vargas L; Heinonen JE; Berglöf A; Mohamed AJ; Nore BF; Vihinen M; Smith CI
Immunol Rev; 2005 Feb; 203():200-15. PubMed ID: 15661031
[TBL] [Abstract][Full Text] [Related]
19. The Role of Bruton's Tyrosine Kinase in Immune Cell Signaling and Systemic Autoimmunity.
Rip J; Van Der Ploeg EK; Hendriks RW; Corneth OBJ
Crit Rev Immunol; 2018; 38(1):17-62. PubMed ID: 29717662
[TBL] [Abstract][Full Text] [Related]
20. Bruton's tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor alpha production.
Horwood NJ; Mahon T; McDaid JP; Campbell J; Mano H; Brennan FM; Webster D; Foxwell BM
J Exp Med; 2003 Jun; 197(12):1603-11. PubMed ID: 12810683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
